Metraipolis › archive › dc_770ec8522782

Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up — Europe PMC PMID:42078821

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42078821
DOI
10.1016/j.rpth.2026.103405
License (as archived)
solo-consultazione
Archived
2026-11-06T08:05:31.461Z
SHA-256 of the archived text
6217329ae056782ae3698900ddfaf0f063d8954ca26756aee043cbdf3f22f1f3
Stable URL of this page
https://metraipolis.com/documento/dc_770ec8522782

How to cite

Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up — Europe PMC PMID:42078821 — Europe PMC (en), https://europepmc.org/article/MED/42078821 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_770ec8522782 (Metraipolis archive dc_770ec8522782, sha256 6217329ae056782ae3698900ddfaf0f063d8954ca26756aee043cbdf3f22f1f3)
BibTeX
@misc{dc770ec8522782,
  title = {Daratumumab for relapsed refractory immune thrombotic thrombocytopenic purpura: initial response and long-term follow-up — Europe PMC PMID:42078821},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42078821},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_770ec8522782; sha256 6217329ae056782ae3698900ddfaf0f063d8954ca26756aee043cbdf3f22f1f3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42078821. Agents can read the archived copy with the MCP tool read_document.